Recent Updates
Recently added Catalysts
BCRX Positive Sentiment Score: 70/100

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Tuesday, June 3, 2025 1 min read
Key Takeaway: BioCryst Pharmaceuticals announced the granting of restricted stock units (RSUs) to seven newly-hired employees as part of their inducement for joining the company. The grants, which cover 47,250 shares of common stock, were made in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest over four years, contingent upon continuous employment. This initiative shows BioCryst's strategy to enhance its workforce and align employee interests with company performance.

Market Sentiment Analysis

POSITIVE FACTORS

  • BioCryst is expanding its workforce by hiring new employees.
  • The grant of RSUs indicates a commitment to employee retention and motivation.
  • The company's adherence to Nasdaq regulations reflects good governance.

Full Press Release Details

RESEARCH TRIANGLE PARK, N.C., June 03, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the compensation committee of BioCryst’s board of directors granted seven newly-hired employees restricted stock units (RSUs) covering an aggregate of 47,250 shares of BioCryst common stock. The RSUs were granted as of June 2, 2025, as inducements material to each employee entering into employment with BioCryst. The RSUs were granted in accordance with Nasdaq Listing Rule 5635(c)(4).
The RSUs vest in four equal annual installments beginning on the one-year anniversary of the grant date, in each case subject to the new employee’s continued service with the company. The RSUs are subject to the terms and conditions of BioCryst’s Inducement Equity Incentive Plan and a restricted stock unit agreement covering the grant.
About BioCryst Pharmaceuticals

Frequently Asked Questions

What is the purpose of the RSUs granted by BioCryst?

The RSUs were granted to seven new employees as an inducement for joining BioCryst.

How many shares were granted in the RSUs?

The RSUs cover an aggregate of 47,250 shares of BioCryst common stock.

When do the RSUs begin to vest?

The RSUs vest in four annual installments starting on the one-year anniversary of the grant.

What rules govern the RSU grants?

The RSUs are granted according to Nasdaq Listing Rule 5635(c)(4) and company policies.

What conditions apply to the RSUs?

The RSUs are subject to continued service and the terms of BioCryst’s incentive plan.

Tags: BCRX Viatris Investor Conferences Healthcare BioCryst Pharmaceuticals RSUs Nasdaq employee compensation
Last updated: Jun 3, 2025